<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: The nosologic field of <z:e sem="disease" ids="C0016514" disease_type="Disease or Syndrome" abbrv="">aphthosis</z:e> is not well defined </plain></SENT>
<SENT sid="1" pm="."><plain>While criteria for <z:chebi fb="6" ids="22696">Beh</z:chebi>Ã§et's disease (BD) are lacking in severe unipolar or bipolar <z:e sem="disease" ids="C0016514" disease_type="Disease or Syndrome" abbrv="">aphthosis</z:e>, these disorders however lead to an important impairment of quality of life </plain></SENT>
<SENT sid="2" pm="."><plain>The aim of this study was to assess the relationship between severe <z:e sem="disease" ids="C0016514" disease_type="Disease or Syndrome" abbrv="">aphthosis</z:e> and BD </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Records of <z:hpo ids='HP_0000001'>all</z:hpo> patients hospitalized for <z:e sem="disease" ids="C0016514" disease_type="Disease or Syndrome" abbrv="">aphthosis</z:e> or BD during a 20-year period were reviewed </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: According to clinical data, cases (n = 104) were classified as unipolar <z:e sem="disease" ids="C0016514" disease_type="Disease or Syndrome" abbrv="">aphthosis</z:e> (group I, n = 53), bipolar <z:e sem="disease" ids="C0016514" disease_type="Disease or Syndrome" abbrv="">aphthosis</z:e> (group II, n = 30) or BD (group III, n = 21) </plain></SENT>
<SENT sid="5" pm="."><plain>The characteristics of <z:e sem="disease" ids="C0038363" disease_type="Disease or Syndrome" abbrv="">aphthae</z:e> (number, localization, recurrences, presence of scars) were similar in <z:hpo ids='HP_0000001'>all</z:hpo> groups </plain></SENT>
<SENT sid="6" pm="."><plain>Specific cutaneous manifestations (<z:hpo ids='HP_0010783'>erythema</z:hpo> nodosum, <z:e sem="disease" ids="C0406191" disease_type="Disease or Syndrome" abbrv="">pseudofolliculitis</z:e>, papulonodules) were present in 15, 17 and 95% of patients of groups I, II and III </plain></SENT>
<SENT sid="7" pm="."><plain>Cutaneous puncture hypersensitivity was present in 14 out of 18 patients of group III and no patient of the two other groups </plain></SENT>
<SENT sid="8" pm="."><plain>At least one extramucous specific manifestation (cutaneous, ophthalmologic, neurologic, articular, vascular) was present in 43% of patients of group I and II, and 100% in group III </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION: These data support the hypothesis of a continuous spectrum linking severe <z:e sem="disease" ids="C0016514" disease_type="Disease or Syndrome" abbrv="">aphthosis</z:e> to BD </plain></SENT>
</text></document>